DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 22114
EU - Europa 6755
AS - Asia 3076
OC - Oceania 29
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 6
Totale 32023
Nazione #
US - Stati Uniti d'America 22081
CN - Cina 1952
DE - Germania 1929
UA - Ucraina 1572
IT - Italia 1103
TR - Turchia 976
GB - Regno Unito 594
FI - Finlandia 364
SE - Svezia 356
RU - Federazione Russa 333
PL - Polonia 239
BE - Belgio 80
FR - Francia 75
VN - Vietnam 56
AU - Australia 27
CA - Canada 27
RO - Romania 21
IR - Iran 20
IN - India 18
BR - Brasile 17
IE - Irlanda 15
ES - Italia 13
JP - Giappone 12
EU - Europa 11
NL - Olanda 11
CH - Svizzera 10
KR - Corea 8
GR - Grecia 7
IQ - Iraq 6
MX - Messico 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
ID - Indonesia 5
CZ - Repubblica Ceca 4
EG - Egitto 4
HK - Hong Kong 4
LU - Lussemburgo 4
MD - Moldavia 4
AM - Armenia 3
AR - Argentina 3
DK - Danimarca 3
EE - Estonia 3
HR - Croazia 3
PT - Portogallo 3
TW - Taiwan 3
AT - Austria 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
IL - Israele 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
GE - Georgia 1
HU - Ungheria 1
LT - Lituania 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 32023
Città #
Fairfield 3221
Woodbridge 3031
Houston 2106
Jacksonville 1824
Chandler 1735
Ann Arbor 1603
Wilmington 1201
Ashburn 1172
Seattle 1148
Cambridge 941
Izmir 684
Nanjing 532
Ferrara 448
Princeton 441
Beijing 361
San Diego 289
Boardman 286
Warsaw 225
Addison 209
Nanchang 150
Shenyang 146
Dearborn 134
Milan 124
Bremen 115
Hebei 107
Tianjin 99
Jiaxing 96
Redwood City 86
Brussels 77
Changsha 75
Mountain View 68
Norwalk 67
Falls Church 57
Dong Ket 56
Zhengzhou 52
Jinan 50
San Mateo 48
Kunming 42
Ningbo 39
Guangzhou 36
London 36
Orange 35
Auburn Hills 32
Helsinki 31
Des Moines 30
Indiana 30
Chicago 26
Augusta 25
Los Angeles 25
Taizhou 24
Philadelphia 23
Hangzhou 22
Rome 22
Shanghai 19
Redmond 18
Verona 18
Lanzhou 16
Monmouth Junction 16
Haikou 15
New York 15
Munich 14
Padova 14
Leawood 13
Bologna 12
Montréal 10
Changchun 9
San Francisco 9
Ardabil 8
Catania 8
Hefei 8
Napoli 8
Walnut 8
Ferrara di Monte Baldo 7
Ottawa 7
Washington 7
Berkeley 6
Calvisano 6
Fuzhou 6
Menlo Park 6
Saint Albans 6
Salerno 6
Sheffield 6
Andover 5
Bozeman 5
Chengdu 5
Palermo 5
São Paulo 5
Trento 5
Vancouver 5
Asheboro 4
Cleveland 4
Dallas 4
Jakarta 4
La Mancha 4
Mcallen 4
Mumbai 4
Oristano 4
Perugia 4
Ponte San Pietro 4
San Donà Di Piave 4
Totale 23922
Nome #
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 283
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 187
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 168
P2X7 targeting inhibits growth of human mesothelioma 165
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 164
IL PROCESSO INFIAMMATORIO 162
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. 154
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 145
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 145
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP 145
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 142
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 140
Purinergic signaling in the immune system 136
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 135
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 132
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. 129
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 128
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 126
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 125
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 124
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 124
The antibiotic polymyxin B modulates P2X7 receptor function 123
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 123
Role of P2X7 receptor in host response to melanoma 121
Extracellular purines, purinergic receptors and tumor growth 121
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 121
Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. 120
The P2X7 receptor is a key modulator of aerobic glycolysis. 120
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 119
Expression of P2X7 receptor increases in vivo tumor growth 119
Purinoceptor function in the immune system 118
The P2X7 receptor: a key player in IL-1 processing and release 118
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 118
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 117
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. 117
The P2X7 receptor-interleukin-1 liaison 117
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 116
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 116
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity. 115
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1 and protects from apoptosis. 115
null 115
P2 receptors in cancer progression and metastatic spreading 114
ATP-mediated cytotoxicity in microglial cells 113
The antibiotic polymyxin B modulates P2X7 receptor function 113
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 113
Purinergic regulation of airway inflammation 112
Activation of muscarinic receptors in PC12 cells. Correlation between cytosolic Ca2+ rise and phosphoinositide hydrolysis. 112
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 112
null 111
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 111
null 111
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 111
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 111
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 110
Insight on P2X7 receptor role as oncogene 109
Extracellular nucleotides and nucleosides as signalling molecules 109
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 109
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 108
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 107
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 107
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 106
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 106
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. 105
Sidedness of e- donation and stoichiometry of H+ pumps at sites II + III in mitochondria from rat liver. 105
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 105
Activation of muscarinic receptors in PC12 cells. Stimulation of Ca2+ influx and redistribution. 104
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease 104
Role of the P2X7 receptor in tumor-associated inflammation 104
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 103
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor containing a tyrosine moiety 103
null 103
Cell-mediated cytotoxicity: ATP as an effector and the role of target cells 103
The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. 103
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. 102
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 102
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. 102
P2 purinoceptors in the immune system 102
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 102
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 101
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes 101
Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. 101
The P2X7 receptor : from ion channel to oncogene 101
null 100
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production 100
The P2X7 Receptor in Infection and Inflammation 100
Extracellular ATP activates transcription factor NFAT in mouse microglial cells 100
P2X7 receptor and polykarion formation 99
Reduced loading of intracellular Ca2+ stores and downregulation of capacitative Ca2+ influx in Bcl-2-overexpressing cells 99
Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils. 99
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 99
P2X receptors and inflammation 99
Molecular machinery and signaling events in apoptosis 99
Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive p2y receptors 98
Effect of cytochalasins on cytosolic-free calcium concentration and phosphoinositide metabolism in leukocytes. 98
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling 98
ATP receptors and giant cell formation 98
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 98
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 98
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 98
Purinergic signalling between axons and microglia 97
Totale 11676
Categoria #
all - tutte 64257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1203
Totale 65460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018466 0000 00 00 030812731
2018/20195541 166122230214 12883 60934 4118179341793
2019/20207370 12062462301083 503907 653776 612673311170
2020/20215249 457432230571 286530 223597 202659703359
2021/20224501 123468260157 278213 237250 1973564341528
2022/20233720 486173139487 685598 142463 547000
Totale 32640